RankingsPricing
  1. US-listed companies
  2. Edwards Lifesciences Corp
  3. Financials
  4. Working capital

Edwards Lifesciences CorpEW

Market cap
$49.9B
P/E ratio
SummaryFinancials
Period EndWorking capital (Million USD)YoY (%)
Dec 31, 20241,498-13.98%
Dec 31, 20231,742+32.30%
Dec 31, 20221,317+19.21%
Dec 31, 20211,104-1.43%
Dec 31, 20201,120+11.58%
Dec 31, 20191,004+7.98%
Dec 31, 2018930+8.14%
Dec 31, 2017860+29.31%
Dec 31, 2016665+12.45%
Dec 31, 2015591+12.31%
Dec 31, 2014527-6.47%
Dec 31, 2013563+6.75%
Dec 31, 2012527+14.63%
Dec 31, 2011460+6.19%
Dec 31, 2010433

Income Statement

RevenueRevenue growth (%)Cost of revenueGross profitGross margin (%)Research & developmentSelling, general & administrativeOperating margin (%)Operating income Operating expenses Income before tax Pretax margin (%)Provision for income taxesEffective tax rate (%)Net income Net income margin (%)Earnings per shareDiluted EPSAdjusted EPSDividend payout ratio (%)Dividend per shareAdjusted DPSEBITDAEBITDA margin (%)

Balance Sheet

Cash and cash equivalents Marketable securities, current Total cash & short-term investmentsAccounts receivable, netInventoriesTotal current assetsProperty, plant and equipment, netMarketable securities, non-current Total non-current assetsTotal assets Accounts payableShort-term debtLong-term debt, current Total current liabilitiesLong-term debt, non-current Total non-current liabilitiesTotal liabilities Common stock and paid-in capital Retained earningsStockholders' equityTotal debtNet debtD/E ratio (%)Working capital

Cash Flow

Depreciation & amortizationStock-based compensationCash from operations Capital expendituresCash from investing Payments for dividends Repurchases of common stockProceeds from issuance of term debt, netRepayments of term debtCash from financing Free cash flowFCF margin (%)